A test is described that could replace bacitracin susceptibility for presumptive identification of group A streptococci as well as 6.5% NaCl agar tolerance for presumptive identification of enterococcal streptococci. The Bacitracin differential disks have been used for many years to distinguish presumptively between group A and non-group A beta-hemolytic streptococci (7). One potential weakness in the interpretation of the bacitracin result has been lack of specificity. Although nearly all group A streptococci are susceptible to bacitracin (positive presumptive identification), 5 to 20% of the beta-hemolytic non-group A streptococci may be susceptible, resulting in misidentification of them as group A streptococci (3, 8) .
Bacitracin differential disks have been used for many years to distinguish presumptively between group A and non-group A beta-hemolytic streptococci (7) . One potential weakness in the interpretation of the bacitracin result has been lack of specificity. Although nearly all group A streptococci are susceptible to bacitracin (positive presumptive identification), 5 to 20% of the beta-hemolytic non-group A streptococci may be susceptible, resulting in misidentification of them as group A streptococci (3, 8) .
Gunn (4) first reported the use of SXT (23.75 ,g of sulfamethoxazole and 1.25 ,ug of trimethoprim) disks with the bacitracin disk to improve the presumptive differentiation of group A from non-group A beta-hemolytic streptococci. We have expanded this presumptive test scheme to include the CAMP, bile-esculin, and 6.5% NaCl tolerance tests with the bacitracin and SXT disks in an effort to further improve the presumptive identification of group A as well as other streptococci (3) . Approximately 98% of the group A streptococci tested have been correctly identified by this scheme (3); 6 .5% NaCl agar (salt agar) has been used to differentiate between enterococcal and nonenterococcal group D streptococci in the scheme. Sterile paraffin has been added to the surface of the salt agar to prevent the hydroscopic salt quadrant from accumulating moisture during storage.
However, a recent report presents evidence that the paraffin wax-coated salt agar does not support the growth of all enterococcal group D streptococci (1) . Evidently some of the residual wax on the surface of the salt agar is inhibitory to some enterococcal strains. The failure of enterococci to grow on the salt agar could lead to their misidentification, a potentially serious error because patients with enterococcal infections are managed differently from those with other streptococcal infections.
The test that can replace the bacitracin and 6.5% NaCl tolerance tests uses an agar medium containing L-pyrrolidonyl-,-naphthylamide (PYR) to identify group A and enterococcal streptococci. This test is a modification of the test for L-pyrrolidine hydrolysis described by J. Godsey, R. Schulman, and L. Eriquez (Abstr. Annu. Meet. Am. Soc. Microbiol. 1981, C84, p. 276). The evidence suggests that the agar-based PYR test is more specific than the bacitracin test for group A streptococci and is at least as specific as the 6.5% NaCl tolerance test for enterococci.
MATERIALS AND METHODS All of the streptococcal isolates used were from human specimens submitted to the Streptococcus Laboratory, Centers for Disease Control, Atlanta, Ga. by federal, state, and city public health departments. Body sites from which they were obtained include, throat, skin, wounds, blood, and cerebrospinal fluid. All strains were identified by conventional serological (Lancefield extracts) and physiological tests (2 Bacitracin susceptibility testing was performed on the beta-hemolytic strains according to previously described procedures (2) .
The presumptive identification of the streptococci is based on the test results listed in Table 1 . RESULTS
The presumptive identification of 400 strains of streptococci and aerococci is given in Table 2 .
Of the beta-hemolytic streptococci, only two were misidentified by the presumptive test scheme. Of the enterococcus strains (S. faecalis, S. faecium, S. durans, and S. avium), three strains of S. faecium were incorrectly identified. One S. faecium strain was presumptively identified as a group D nonenterococcus because it gave a negative PYR test, and two strains remained unidentified because they gave only a positive PYR test. This reaction pattern (non-beta-hemolytic, CAMP, and bile-esculin negative, PYR positive) is not accounted for in the scheme summarized in Table 1 , thus the strains remained unidentified.
All 30 strains of group D nonenterococci (S. bovis biotypes I and II and S. equinus) were correctly identified.
Of 112 viridans streptococci, 20 were misidentified as group D nonenterococci because they gave positive bile-esculin reactions. Among the viridans species, half (16 of 32) of the S. intermedius strains tested were misidentified as group D nonenterococcal streptococci.
All five nonhemolytic group B streptococci were correctly identified.
Three different patterns of reactions resulted from testing 13 strains of aerococci. Six strains were identified as group D enterococci, one was identified as a group D nonenterococcus, and six others remained unidentified because only the PYR reactions were positive. DISCUSSION The presumptive identification of streptococci has two advantages over confirmatory identification procedures. The cost of the reagents for presumptive testing is generally less than that for confirmatory testing, and presumptive tests are usually less complex to perform than are confirmatory tests. Although both the bacitracin and PYR tests are presumptive tests for identification of group A streptococci, the PYR test is more specific than the bacitracin test because no group C or G beta-hemolytic streptococci were PYR positive, but 14.5% of these same strains were positive by the bacitracin test. The sensitivity of the bacitracin and PYR tests appears equal. True S. pyogenes strains are probably susceptible to bacitracin and give positive PYR tests, whereas atypical group A streptococcal strains (non-M-protein-containing group A streptococci) are resistant to bacitracin and give negative PYR tests. We tested several of these atypical group A streptococci in in vitro bactericidal tests, and none of them has survived. This indicates that they do not have the antiphagocytic antigens (M protein) possessed by most, if not all S. pyogenes strains. These atypical group A streptococcal strains are more similar to group F strains morphologically and physiologically than they are to typical group A strains (unpublished observations).
CAMP-negative group B streptococci have been previously reported (3, 10) . We have reported that 2 of 141 group B strains were CAMP negative (3) . In this report, 1 were negative in the PYR or salt agar tolerance tests grew in 6.5% NaCl heart infusion broth (2) . We suggest that the PYR test be used for screening, and for strains that give atypical reactions, the tube test for both bile-esculin and salt tolerance should be used for confirmation. Another alternative is to perform all of the tests described in the American Society for Microbiology manual (2) to complete the serological and physiological identification of the strains.
In this study an appreciable number of viridans streptococci (18%) were positive on bileesculin agar, and a few enterococci (2.8%) were negative on bile-esculin agar. We have previously reported that 12 of 171 (7%) viridans streptococci were positive on bile-esculin agar and 4 of 120 (3.3%) enterococci were negative on bileesculin agar (3). Since we selected test strains from recently submitted specimens; the high percentage of bile-esculin-positive viridans strains in the sample is probably due to an increased interest in the identification of S. bovis. An appreciable number of bile-esculinpositive salt tolerance test-negative strains submitted to our laboratory are not S. bovis but S. MG-intermedius. This does not decrease the value of the PYR test for identifying enterococci, but it does point out the potential error in presumptive identification of S. bovis. This is not a serious error because the antimicrobial susceptibilities of the group D nonenterococcal and viridans strains are similar (9) , and the antimicrobial treatment of the infections may be the same. However, the misidentification of blood culture isolates as S. bovis may lead to erroneous assumptions concerning a diagnosis of colonic cancer (5 
